Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Methodology - Microsurgery Market
3.2 Data Mining
3.3 Secondary Research
3.3.1 Data points received from the secondary research
3.4 Primary Research
3.4.1 Data points received from surgeons & consulting physicians
3.4.2 Data points received from the manufacturer
3.5 FORECASTING TECHNIQUES
3.6 Research Methodology for Market Size Estimation
3.7 DATA TRIANGULATION
3.8 Validation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing demand and cases of microsurgery
4.2.2 Increase in the prevalence of certain conditions needing microsurgery
4.2.3 Increasing acceptance of minimally invasive surgeries and growing per capita income would drive the growth of the market
4.3 Restraints
4.3.1 Complications and side-effects
4.3.2 Cost of microsurgery
4.3.3 Limitation due to patients' anatomy
4.4 Opportunities
4.4.1 Technological advancement with the assistance of R&D
4.5 Challenges
4.5.1 Scarcity of trained professionals
5 Market Factor Analysis
5.1 Porter's Five Force Analysis
5.1.1 Threat from a New Entrant
5.1.2 Bargaining Power of Buyer
5.1.3 Bargaining Power of Supplier
5.1.4 Threat from substitute
5.1.5 Intensity of Competitive Rivalry
5.2 Value Chain Analysis
5.2.1 Raw Material
5.2.2 Supplier
5.2.3 Manufacturer
5.2.4 Distributor
5.2.5 Customer-Retailer
5.2.6 Consumer
5.3 Investment Opportunity Analysis
5.3.1 Investment risks
5.3.2 Market outlook
5.3.3 Competitors
5.3.4 Projections
5.4 Pricing analysis
6 Global Microsurgery Market, By Procedure
6.1 Introduction
6.2 Transplantation
6.3 Replantation
6.4 Free Flap Tissue Transfer
6.5 Vascular Anastomoses
7 Global Microsurgery Market, By Application
7.1 Introduction
7.2 General Surgery
7.3 Neurosurgery
7.4 Ophthalmology
7.5 Reconstructive & Plastic Surgery
7.6 Oncology
?
8 Global Microsurgery Market, By Equipment
8.1 Introduction
8.2 Microsurgical Instruments
8.3 Microscope
8.4 Suture Materials
9 Global Microsurgery Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Ambulatory Surgical Centers
9.4 Research Organizations
10 Global Microsurgery Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Republic of Korea
10.4.5 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1.1 Introduction
12 Company Profile
12.1 S&T AG
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Aesculap, Inc., a B. Braun company
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Synovis Micro Companies Alliance, Inc.
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Ethicon Inc.
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 Stryker Corporation
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Smith & Nephew
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Alcon (Novartis)
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Zimmer Biomet Holdings
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Medtronic Plc
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Carl Zeiss Meditec AG
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Peter Lazic GmbH
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products Offering
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
12.12 Microsurgery Instruments, Inc.
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products Offering
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategy
12.13 Tisurg medical instruments Co., Ltd.
12.13.1 Company Overview
12.13.2 Financial Overview
12.13.3 Products Offering
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.13.6 Key Strategy
12.14 Microline Surgical
12.14.1 Company Overview
12.14.2 Financial Overview
12.14.3 Products Offering
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.14.6 Key Strategy
12.15 AROSurgical Instruments
12.15.1 Company Overview
12.15.2 Financial Overview
12.15.3 Products Offering
12.15.4 Key Developments
12.15.5 SWOT Analysis
12.15.6 Key Strategy
12.16 Halma plc
12.16.1 Company Overview
12.16.2 Financial Overview
12.16.3 Products Offering
12.16.4 Key Developments
12.16.5 SWOT Analysis
12.16.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print
